| 产品名称 | ReVacc Scientific U85H22 | Lenti-Pseudovirus_SARS-CoV (2003 strain) Spike with luciferase reporter |
|---|---|
| 目录号 | U85H22 |
| 别名 | Lenti-Pseudovirus_SARS-CoV (2003 strain) Spike with luciferase reporter |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| U85H22 | 1.1ml; 5.5ml | 咨询 | 咨询 |
ReVacc Scientific U85H22 | Lenti-Pseudovirus_SARS-CoV (2003 strain) Spike with luciferase reporter
品名：Lenti-Pseudovirus_SARS-CoV (2003 strain) Spike with luciferase reporter
货号：U85H22
品牌：ReVacc Scientific
规格：1.1ml; 5.5ml
产品描述
Organism：SARS-Related Coronavirus (virus caused 2003 outbreak)
This pseudotyped virus uses lentiviral vectors to package Spike (S) protein of SARS-CoV (Severe Acute Respiratory Syndrome, GenBank: DQ412594.1), which was designed by codon optimizing the full-length S sequence for mammalian expression. Infection of cells with this pseudotyped virus carrying luciferase reporter results in detectable luciferase activity. See our titration result showing the undiluted pseudovirus (green) generates signal 10,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of SARS Positive control mAb and 2 published neutralizing mAbs (CR3022 and 80R) by using this pseudotyped virus, see results.
